摘要 |
Neuroleptic malignant syndrome (NMS) is a rare disorder that manifests with rigidity, fever, dysautonomia, and changes in mental status. Haloperidol, an atypical antipsychotic drug, has reportedly been used to treat agitation in patients with traumatic brain injury (TBI).
We herein present the case of a patient with TBI and agitation who, having received haloperidol, developed NMS. The syndrome was successfully treated with supportive care and cessation of haloperidol administration. |